Clinical Trials Browser

Phase 3 × INDUSTRY × Mebendazole × Clear all

NCT02201381 2022-07-18

METRICS

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms